Stay updated with breaking news from Dermpath Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Quest Diagnostics said it will acquire PathAI Diagnostics in Memphis, TN, the business of PathAI that provides anatomic and digital pathology laboratory services, to accelerate the adoption of digital and AI pathology.
Quest Diagnostics (NYSE:DGX – Get Free Report) and BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings. Profitability This table compares Quest Diagnostics and […]
Quest Diagnostics (NYSE:DGX – Get Free Report) and BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, valuation and dividends. Insider and Institutional Ownership 88.1% of Quest […]
/PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today announced the launch of MelaNodal...
Quest Diagnostics (NYSE: DGX) watched its shares move earthward Tuesday, as the leading U.S. provider of diagnostic information services, today announced the launch of MelaNodal Predict™, a highly advanced predictive gene expression test to help personalize ...